IDEXX Laboratories (IDXX)
(Delayed Data from NSDQ)
$472.35 USD
+3.17 (0.68%)
Updated Sep 6, 2024 04:00 PM ET
After-Market: $470.94 -1.41 (-0.30%) 7:58 PM ET
4-Sell of 5 4
D Value C Growth F Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$472.35 USD
+3.17 (0.68%)
Updated Sep 6, 2024 04:00 PM ET
After-Market: $470.94 -1.41 (-0.30%) 7:58 PM ET
4-Sell of 5 4
D Value C Growth F Momentum D VGM
Zacks News
5 Stocks that Outperformed the S&P 500 in Q1
by Zacks Equity Research
First quarter was quite impressive and we have selected five top-ranked stocks that surpassed the S&P 500 index during the period.
Varian (VAR) Eclipse Software Tops in International Studies
by Zacks Equity Research
Varian Medical Systems, Inc. (VAR) recently announced that its Eclipse treatment planning software has topped in two competitive international plan studies.
PAREXEL (PRXL) Launches Sensor for Clinical Trial Market
by Zacks Equity Research
PAREXEL International Corporation (PRXL), a global biopharmaceutical services company and provider of clinical research and logistics, recently announced the launch of its patient sensor solution.
AngioDynamics (ANGO) Beats on Q3 Earnings, Raises 2017 View
by Zacks Equity Research
AngioDynamics Inc. (ANGO), a leading provider of minimally invasive medical devices, reported adjusted earnings of 19 cents per share in the third quarter of fiscal 2017.
New Zacks Rank Strong Buy Stocks Breaking to Highs
by David Bartosiak
Today???s Daily Dive included a brief overview of the stellar action on crude oil, including intermediate term targets for the contract.
Envision (EVHC) Teams Up with Lyft to Focus on Transportation
by Zacks Equity Research
Envision Healthcare Corporation (EVHC) recently announced that it has teamed up with on-demand transportation service provider Lyft.
Cerner (CERN) Banks on RCM & PH Platforms, Competition Rife
by Zacks Equity Research
On Mar 29, we issued an updated research report on North Kansas City, MO-based Cerner Corporation (CERN) ??? a leading global provider of healthcare information technology solutions (HCIT).
Here's Why You Should Steer Clear of Mednax (MD) for Now
by Zacks Equity Research
Over the past 6 six months, shares of Mednax (MD) have gained 4.9%., underperforming the 9.8% increase logged by the Zacks categorized Medical - Hospital industry.
Intuitive Surgical Hits 52-Week High on Multiple Positives
by Zacks Equity Research
Shares of leading provider of robotic-assisted surgery, Intuitive Surgical, Inc. (ISRG) rallied to a new 52-week high of $770.28 on Mar 28, closing a tad lower at $764.47.
3 Medical Device Stocks to Brave Policy Uncertainty
by Zacks Equity Research
We believe stocks with strong fundamentals that also have a significant share of their business overseas may well brace themselves in the on-going conundrum. They will make lucrative additions to your portfolio.
IDEXX (IDXX) Poised on Strong Fundamentals, Innovations
by Zacks Equity Research
On Mar 14, we issued an updated research report on IDEXX Laboratories, Inc. (IDXX).
ABIOMED Impella Heart Pump Reduces Kidney Injury during PCI
by Zacks Equity Research
A new study demonstrates that ABIOMED's flagship Impella 2.5 heart pump can reduce the risk of acute kidney injury during high-risk percutaneous coronary intervention (PCI).
Cooper Companies (COO) Receives ISO 15189 Accreditation
by Zacks Equity Research
The Cooper Companies Inc. (COO) announced that its London and Nottingham-based laboratories received the International Organization for Standardization 15189 accreditation.
C. R. Bard (BCR) Well Poised for Growth, Macro Woes Remain
by Zacks Equity Research
We issued an updated research report on C. R. Bard Inc. (BCR) on Mar 8, 2017.
Baxter (BAX) Hits a 52-Week High: What's Driving the Stock?
by Zacks Equity Research
Share price of Baxter International Inc. (BAX), a global medical technology company, rallied to a new 52-week high of $51.43 on Mar 8, eventually closing a bit lower at $51.36.
Intersect ENT: FDA Submission of RESOLVE Implant, Stock Up
by Zacks Equity Research
Intersect ENT, Inc (XENT) recently announced the submission of a New Drug Application (NDA) approval with the U.S. FDA for reviewing its investigational RESOLVE steroid releasing implant.
OPKO Health (OPK) Launches Prenatal Testing Tool ClariTest
by Zacks Equity Research
OPKO Health Inc. (OPK) recently announced the launch of a non-invasive medical test to detect fetal abnormalities.
Meridian (VIVO) to Provide LeadCare Testing System in Africa
by Zacks Equity Research
Meridian Bioscience, Inc. (VIVO), a renowned life sciences company, recently signed an exclusive distribution agreement with Biofirm Technologies.
TransEnterix (TRXC) Reports Wider-Than-Expected Loss in Q4
by Zacks Equity Research
TransEnterix, Inc. (TRXC) reported a loss of 12 cents per share in the fourth quarter of 2016, wider than the Zacks Consensus Estimate of a loss of 11 cents.
Masimo Announces Availability of RD SedLine Brain Sensors
by Zacks Equity Research
Masimo Corporation (MASI) recently announced the availability of the RD SedLine EEG sensor, which can be used with the company???s flagship SedLine Brain Function Monitoring technology.
Allscripts (MDRX) Acknowledged by LPP's CDIS Framework
by Zacks Equity Research
Allscripts Healthcare Solutions, Inc. (MDRX) recently announced that it has been accepted and acknowledged by the NHS London Procurement Partnership (LPP) in its Clinical and Digital Information Systems (CDIS) Framework.
IDEXX (IDXX) Up 5.8% Since Earnings Report: Can It Continue?
by Zacks Equity Research
IDEXX (IDXX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Top Ranked Momentum Stocks to Buy for February 14th
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, February 14th:
Can the Rally in IDEXX Laboratories (IDXX) Shares Continue?
by Zacks Equity Research
IDEXX Laboratories, Inc. (IDXX) has been on the move lately as the stock has risen by 16.5% in the past four weeks, and it is currently trading well above its 20-Day SMA
Looking for a Growth Stock? Why It is Time to Focus on IDEXX Laboratories (IDXX)
by Zacks Equity Research
IDEXX Laboratories (IDXX) is seeing solid earnings estimate revision and has a favorable Zacks rank, making it well positioned for future earnings growth.